Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150,495 | 100 | 57.0% |
| Consulting Fee | $62,410 | 30 | 23.7% |
| Food and Beverage | $34,351 | 1,779 | 13.0% |
| Travel and Lodging | $16,257 | 60 | 6.2% |
| Education | $292.56 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $145,440 | 277 | $0 (2024) |
| Amgen Inc. | $59,184 | 145 | $0 (2024) |
| ABBVIE INC. | $18,449 | 202 | $0 (2024) |
| Allergan, Inc. | $12,738 | 66 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $3,715 | 129 | $0 (2024) |
| Novo Nordisk Inc | $3,171 | 185 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $3,066 | 7 | $0 (2017) |
| Eli Lilly and Company | $2,250 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $1,940 | 111 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,750 | 98 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,238 | 258 | Amgen Inc. ($12,316) |
| 2023 | $62,236 | 348 | Amgen Inc. ($30,898) |
| 2022 | $42,402 | 303 | Janssen Pharmaceuticals, Inc ($21,318) |
| 2021 | $29,384 | 216 | Janssen Pharmaceuticals, Inc ($19,617) |
| 2020 | $22,474 | 206 | Janssen Pharmaceuticals, Inc ($11,687) |
| 2019 | $14,101 | 188 | Janssen Pharmaceuticals, Inc ($11,027) |
| 2018 | $32,535 | 237 | Janssen Pharmaceuticals, Inc ($24,097) |
| 2017 | $35,435 | 226 | Janssen Pharmaceuticals, Inc ($29,830) |
All Payment Transactions
1,982 individual payment records from CMS Open Payments — Page 80 of 80
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/22/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 01/19/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Hypertriglyceridemia | ||||||
| 01/16/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/10/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Respiratory | ||||||
| 01/10/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Hypertriglyceridemia | ||||||
| 01/09/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
| 01/05/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,238 | 2,124 | $281,405 | $103,488 |
| 2022 | 12 | 1,568 | 2,729 | $385,415 | $128,719 |
| 2021 | 13 | 1,832 | 3,628 | $461,360 | $277,409 |
| 2020 | 21 | 1,713 | 3,094 | $384,335 | $201,560 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 169 | 739 | $88,680 | $44,956 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 424 | $86,920 | $20,787 | 23.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 74 | 127 | $18,415 | $10,874 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 166 | $24,070 | $7,461 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 186 | 186 | $37,400 | $6,149 | 16.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 214 | 214 | $5,355 | $4,180 | 78.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 208 | 208 | $6,240 | $4,063 | 65.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 14 | 16 | $4,000 | $2,425 | 60.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $5,600 | $1,444 | 25.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 15 | $3,750 | $1,002 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $975.00 | $147.00 | 15.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 163 | 668 | $80,160 | $38,176 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 310 | 729 | $148,685 | $37,059 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 208 | 416 | $60,250 | $19,805 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 248 | 248 | $49,600 | $8,353 | 16.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 53 | 76 | $11,020 | $5,692 | 51.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 265 | 265 | $7,950 | $5,198 | 65.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 231 | 231 | $5,775 | $4,619 | 80.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 22 | 27 | $9,450 | $3,869 | 40.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 27 | 27 | $6,750 | $3,699 | 54.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $3,250 | $1,480 | 45.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 14 | 14 | $1,400 | $585.57 | 41.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 15 | $1,125 | $183.32 | 16.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 342 | 997 | $165,300 | $99,149 | 60.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 278 | 698 | $76,975 | $51,664 | 67.1% |
About Dr. Michael Attanasio, D.O
Dr. Michael Attanasio, D.O is a Family Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174593958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Attanasio, D.O has received a total of $263,805 in payments from pharmaceutical and medical device companies, with $25,238 received in 2024. These payments were reported across 1,982 transactions from 73 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($150,495).
As a Medicare-enrolled provider, Attanasio has provided services to 6,351 Medicare beneficiaries, totaling 11,575 services with total Medicare billing of $711,176. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Philadelphia, PA
- Active Since 01/25/2006
- Last Updated 12/27/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174593958
Products in Payments
- XARELTO (Drug) $88,517
- Repatha (Biological) $58,259
- INVOKANA (Drug) $56,923
- UBRELVY (Drug) $18,645
- VRAYLAR (Drug) $6,981
- QULIPTA (Drug) $4,968
- JARDIANCE (Drug) $3,377
- Trintellix (Drug) $3,177
- Ozempic (Drug) $1,610
- TRELEGY ELLIPTA (Drug) $1,426
- FARXIGA (Drug) $1,390
- TRULICITY (Drug) $915.48
- Kerendia (Drug) $860.21
- BREZTRI (Drug) $851.93
- ENTRESTO (Drug) $760.82
- Vascepa (Drug) $712.58
- XIFAXAN (Drug) $637.74
- Otezla (Drug) $530.23
- JANUVIA (Drug) $454.48
- SYMBICORT (Drug) $430.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Philadelphia
Dr. Deborah Witt, M.d, M.D
Family Medicine — Payments: $226,164
Jonah Mink, Md, MD
Family Medicine — Payments: $146,427
Celia Ezidiegwu, Md, MD
Family Medicine — Payments: $117,796
Dr. Glenn Rosen, Md, MD
Family Medicine — Payments: $77,390
Dr. Casey Lafferty, D.o, D.O
Family Medicine — Payments: $54,627
Dr. Daniel Schwartz, Do, DO
Family Medicine — Payments: $33,185